389 related articles for article (PubMed ID: 35800375)
21. Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia.
van Gils N; Denkers F; Smit L
Front Oncol; 2021; 11():659253. PubMed ID: 34012921
[TBL] [Abstract][Full Text] [Related]
22. Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions.
Tan Y; Wu Q; Zhou F
Crit Rev Oncol Hematol; 2020 Aug; 152():102993. PubMed ID: 32502928
[TBL] [Abstract][Full Text] [Related]
23. [Progress in the studies of acute myelogenous leukemia stem cell].
Cui JW; Zhang XM; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558
[TBL] [Abstract][Full Text] [Related]
24. Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.
Pelosi E; Castelli G; Testa U
Blood Cells Mol Dis; 2015 Dec; 55(4):336-46. PubMed ID: 26460257
[TBL] [Abstract][Full Text] [Related]
25. [Acute myeloid leukemia stem cells from genomic and immunological perspectives].
Goyama S
Rinsho Ketsueki; 2020; 61(9):1130-1137. PubMed ID: 33162508
[TBL] [Abstract][Full Text] [Related]
26. Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell Quiescence.
O'Reilly E; Zeinabad HA; Nolan C; Sefy J; Williams T; Tarunina M; Hernandez D; Choo Y; Szegezdi E
Front Cell Dev Biol; 2021; 9():662868. PubMed ID: 34589478
[TBL] [Abstract][Full Text] [Related]
27. [Recent progress in leukemic stem cell research for childhood leukemia].
Eguchi M; Eguchi-Ishimae M; Ishii E
Rinsho Ketsueki; 2015 Oct; 56(10):1871-81. PubMed ID: 26458424
[TBL] [Abstract][Full Text] [Related]
28. The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients.
Park MN
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569414
[TBL] [Abstract][Full Text] [Related]
29. [Molecular targeted therapy for leukemic stem cells].
Kikushige Y
Nihon Rinsho; 2015 May; 73(5):811-5. PubMed ID: 25985636
[TBL] [Abstract][Full Text] [Related]
30. Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.
Saha S; Murmu KC; Biswas M; Chakraborty S; Basu J; Madhulika S; Kolapalli SP; Chauhan S; Sengupta A; Prasad P
Front Oncol; 2019; 9():692. PubMed ID: 31448224
[TBL] [Abstract][Full Text] [Related]
31. Targeting acute myeloid leukemia stem cell signaling by natural products.
Siveen KS; Uddin S; Mohammad RM
Mol Cancer; 2017 Jan; 16(1):13. PubMed ID: 28137265
[TBL] [Abstract][Full Text] [Related]
32. Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells.
Peng M; Huang Y; Zhang L; Zhao X; Hou Y
Front Oncol; 2022; 12():899502. PubMed ID: 35574326
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy.
Momparler RL; Côté S; Momparler LF
Epigenomes; 2020 Mar; 4(1):. PubMed ID: 34968237
[TBL] [Abstract][Full Text] [Related]
34. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
[TBL] [Abstract][Full Text] [Related]
35. Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells.
Reinisch A; Chan SM; Thomas D; Majeti R
Semin Hematol; 2015 Jul; 52(3):150-64. PubMed ID: 26111462
[TBL] [Abstract][Full Text] [Related]
36. Aberrant Lipid Metabolic Signatures in Acute Myeloid Leukemia.
Singh P; Murali R; Shanmugam SG; Thomas S; Scott J; Warrier S; Arfuso F; Dharmarajan A; Gandhirajan RK
Stem Cells; 2024 Mar; 42(3):200-215. PubMed ID: 38167958
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
38. Leukemic stem cells as a target for eliminating acute myeloid leukemia: Gaps in translational research.
Khaldoyanidi SK; Hindoyan A; Stein A; Subklewe M
Crit Rev Oncol Hematol; 2022 Jul; 175():103710. PubMed ID: 35588936
[TBL] [Abstract][Full Text] [Related]
39. Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy.
Chen Y; Liang Y; Luo X; Hu Q
Cell Death Dis; 2020 Apr; 11(4):291. PubMed ID: 32341354
[TBL] [Abstract][Full Text] [Related]
40. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
